Lung Cancer
Collection
Collection
- ISSN: 01695002
Published by Elsevier Ireland Ltd
-
Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC) Article
Lung Cancer, 179-186.Hermans, B.C.M., Derks, JL, E. Thunnissen (Erik), van Suylen, RJ, M.A. den Bakker (Michael), H.J.M. Groen (Harry), E.F. Smit (Egbert), Damhuis, RA, E.C. van den Broek (Esther), Stallinga, C.M., et al. Roemen, G.M., E.J. Speel (Ernst-Jan) and A.M.C. Dingemans (Anne-Marie)
January 2019 -
The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer Article
Lung Cancer, 130-135.Degens, J., Sanders, K.J.C., de Jong, E.E.C., H.J.M. Groen (Harry), E.F. Smit (Egbert), J.G.J.V. Aerts (Joachim), Schols, A. and A.M.C. Dingemans (Anne-Marie)
July 2019
-
DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile Article
Lung Cancer, 102-108.Hermans, B.C.M. (B. C.M.), J.L. Derks (Jules L.), E. Thunnissen (Erik), R-J. van Suylen (Robert-Jan), M.A. den Bakker (Michael), H.J.M. Groen (Henk), Smit, E.F. (E. F.), R.A. Damhuis (Ronald), van den Broek, E.C. (E. C.), Ruland, A. (A.), et al. E.J. Speel (Ernst-Jan) and Dingemans, A.M.C. (A. M.C.)
December 2019 -
Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates Article
Lung Cancer, 200-206.E.F. Blom (Erik), K. ten Haaf (Kevin) and H.J. de Koning (Harry)
January 2020
-
Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry Article
Lung Cancer, 107-112.Smit, H.J.M. (H. J.M.), J.G.J.V. Aerts (Joachim), M. Van Den Heuvel (Michel), Hiltermann, T.J.N. (T. J.N.), Bahce, I. (I.), Smit, E.F. (E. F.), Dingemans, A.-M.C. (A. M.C.), Hendriks, L.E. (L. E.), Stigt, J.A. (J. A.), F.M.N.H. Schramel (Franz), et al. H. van Tinteren (Harm) and H.J.M. Groen (Henk)
February 2020 -
Letter to the Editor Article
Lung CancerDegens, J.H.R.J. (J. H.R.J.), Dingemans, A.-M.C. (A-M.C.), A.M.W.J. Schols (Annemie) and Willemsen, A.C.H. (A. C.H.)
March 2020 -
Cost-effectiveness of stereotactic body radiation therapy versus video assisted thoracic surgery in medically operable stage I non-small cell lung cancer: A modeling study Article
Lung Cancer, 89-96.Wolff, H.B. (Henri B.), Alberts, L. (Leonie), N. van der Linden (Naomi), M.L. Bongers (Mathilda), N. Verstegen (Naomi), F.J. Lagerwaard (Frank), Hofman, F.N. (Frederik N.), C.A. Uyl-de Groot (Carin), S. Senan (Suresh), El Sharouni, S.Y. (Sherif Y.), et al. Kastelijn, E.A. (Elisabeth A.), F.M.N.H. Schramel (Franz) and V.M.H. Coupé (Veerle)
March 2020
-
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer Article
Lung Cancer, 9-13.van Veggel, B. (B.), Madeira R Santos, J.F.V. (J.F. Vilacha), Hashemi, S.M.S. (S. M.S.), M.S. Paats (Marthe), K. Monkhorst (Kim), D.A.M. Heideman (Danielle), Groves, M. (M.), Radonic, T. (T.), Smit, E.F. (E. F.), E. Schuuring (Ed), et al. van der Wekken, A.J. (A. J.) and de Langen, A.J. (A. J.)
March 2020